Analysis of disproportionate signal analysis for adverse events associated with eculizumab and tacrolimus combination therapy based on the FDA Adverse Event Reporting System Database

doi:10.3969/j.issn.1672-3384.2026.07.008

Cen LIU, Ruixue LI, Qingfeng YAN, Pengfei JIN, Xin HU, Wenfeng XU, Di CHEN

Clinical Medication Journal ›› 2026, Vol. 24 ›› Issue (7) : 39-47.

PDF(635 KB)

Clinical Medication Journal ›› 2026, Vol. 24 ›› Issue (7) : 39-47. DOI: 10.3969/j.issn.1672-3384.2026.07.008

Original Article

Analysis of disproportionate signal analysis for adverse events associated with eculizumab and tacrolimus combination therapy based on the FDA Adverse Event Reporting System Database

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 24(7): 39-47 https://doi.org/10.3969/j.issn.1672-3384.2026.07.008

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(635 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2026-03-26	2026-07-25
Issue Date
2026-07-31

Please choose a citation manager

Content to export